Skip to main content
Marcelo Blaya, MD, Oncology, North Miami, FL

Marcelo Blaya MD

Breast Cancer


Medical Oncology Memorial Breast Cancer Center Memorial Healthcare System

Join to View Full Profile
  • 2111 Sole Mia WayNorth Miami, FL 33181

  • Phone+1 305-243-5302

  • Fax+1 305-243-0424

Dr. Blaya is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 2001 - 2004
  • Federal University of Rio Grande do Sul School of Medicine
    Federal University of Rio Grande do Sul School of MedicineClass of 1997

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2014 - 2027
  • LA State Medical License
    LA State Medical License 2007 - 2015
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification MedSym EHR, MedSym, Inc., 2013, 2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2017

Publications & Presentations

PubMed

Journal Articles

  • Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast Cancer  
    Rita Nanda, Carla Falkson, Filipa C Lynce, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Reshma Mahtani, Tarah J Ballinger, Kathy D Miller, Brya..., JAMA Oncology

Lectures

  • Moving From Academic Medicine to Private Practice: Lessons and Perspectives 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Authored Content

  • Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerJuly 2020

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: